H.C. Wainwright Reiterates Buy Rating on Unicycive Therapeutics (UNCY)
H.C. Wainwright analyst Ed Arce reiterated a Buy rating and $22.00 price target on Unicycive Therapeutics (NASDAQ: UNCY).The analyst commented ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)